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C 3 Outcome Assessment Methodology in Acute Limb Ischemia
C 3.1 Introduction
The general approach to the assessment of outcomes from the diagnosis and treatment of
patients with PAD is outlined in A 3, Outcome Assessment Methodology in Peripheral Arterial
Disease (p S35). Although the basic methodology remains unchanged for the evaluation of out-
comes in patients treated for ALI, the primary clinical outcomes criteria differ because of its more
serious nature. The risks and outcomes in a patient with an acute reduction in distal blood flow
are proportional to the degree of ischemia (see Recommendation 47, p Sl44). Severity level I is
not dissimilar to chronic CLI, and outcome assessment of patients with this degree of ischemia is
addressed in D 3, Outcome Assessment Methodology in Critical Limb Ischemia (p S188).
Patients with more severe levels of acute limb ischemia share similar risks and outcomes. Those
who present with levels Ila, lIb, and III ALI have both an immediate life-threatening and limb-
threatening problem. Patients with class III ischemia can be subdivided into early and late pre-
sentations. Those with early presentations may have some tissue loss from the forefoot and pro-
longed nerve dysfunction but may benefit from an attempt at restoration of distal perfusion.
Those with late presentations will require major amputation because of advanced extensive tissue
ischemia and necrosis. The risk is not only to limb. Patients with ALI are also at serious risk of
death. The sudden onset of hypoperfusion of the leg leads rapidly to systemic acid-base and elec-
trolyte disorders that impair cardiopulmonary function. Elevated myoglobin levels are associated
with irreversible renal failure. Successful revascularization may induce a severe reperfusion injury,
causing further neuromuscular damage within the extremity. Thirty-day operative mortality in
recent series has ranged from 9.7% to 17% 1,2,3,4,5 but may be as high as 42%in the very elderly»
The therapeutic goals in these ill patients differ from those with lesser degrees of circulatory
impairment. The value of any treatment modality must be assessed accordingly. Patient choices
and expectations are limited. Few therapeutic options exist. Invasive intervention, either percu-
taneous or open, is required. Therefore, both patient survival and limb preservation are major
priorities in the treatment of the patient with acute, limb-threatening lower extremity ischemia.
These priorities must be reflected in the analysisof the effectiveness of the care provided to
these critically ill patients.
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C 3.2
Recommendation 49: Classification of patients with severe acute limb ischemia for out-
comes assessment.
Outcomes assessment for patients who present with acute limb ischemia of severity level
I differs from those who present with severity levels IIa, fib, or III. Therefore, out-
comes assessment of the treatment of acute limb ischemia should be confined to
patients with severity levels IIa, IIb, and III.
Because their limbs are categorically viable, the outcomes evaluation of patients who
present with severity level I should be assessed separately by criteria similar to those
requiring treatment for chronic, severe lower extremity ischemia (see D 3, P 5188).
Clinical Outcomes
Clinical outcomes are parameters that assess the clinical problem only, such as amputation rate,
not those factors that directly impact on the patient's life, such as physical functioning and pain.
For the treatment of ALI, major parameters include: technical success of the treatment;
improvements in physical examination, such as the return of palpable pulses; duplex or angio-
graphic demonstration of patent arterial anatomy; and improvement in distal arterial pressures
and the ankle:brachial pressure index (ABPI). The analysis of periprocedural outcomes in
patients with acute, severe lower extremity ischemia is complicated by the fact that baseline
parameters are frequently absent.
The clinical urgency of advanced leg ischemia or the precarious condition of the patient may
prohibit the acquisition ofmost baseline clinical information and mandates expeditious inter-
vention. Fortunately, a carefully performed physical examination will provide a significant
amount of information. The documentation of the presence or absence ofpulses and sensory or
motor function before treatment establishes important clinical parameters with which postoper-
ative assessments can be compared. The restoration ofpulses, a significant improvement in
ABPI, and patent arteries as visualized by duplex imaging or arteriography after treatment pro-
vide a measure of technical success.
C 3.2.1 Technical Success
Technical success for the treatment of ALI addresses the results obtained by any procedure to
revascularize a specific segment of the arterial tree. The technical success of a procedure used to
treat a patient with ALI is affected by the duration of ischemia and symptoms before treatment.
In the past, an arbitrary limit of 14 days was often used for the duration of new symptoms
when assessing the outcome of any treatment for acute limb ischemia (see also C 4.4, Results of
Surgical and Endovascular Procedures for Acute Limb Ischemia, p S155).
During a clinical procedure, it may seem desirable to track the impact of each technical compo-
nent. Although the removal of clot would seem easy to document, the specific technical success
of an intervention may be difficult to evaluate. The extraction of thrombi from the major ves-
sels of the lower extremity does not guarantee distal reperfusion, This is because of the possibil-
ity of the extension of thrombus into, or shutdown by spasm, edema, or thrombosis, of the
small nutrient vessels that are not visualized by arteriography. Additionally, the complete
removal of clot may reveal a significant underlying occlusive lesion or may be marked by the
appearance of a clinically significant reperfusion injury.
Recommendation 50: Assessment of technical success in relation to duration of acute limbis-
~
Assessment of technical success of a procedure used for the treatment of patients with acute
limb ischemia of severity levels ITa, Ilb, or early ill should be limited to the results obtained
with patients who have had symptoms for a short duration, which should be clearly stated in the
publication.
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Reconunendation 51: Assessment of technical success of multiple interventions
When treatment involves multiple modalities, such as thrombolytic therapy and open
surgery, "technical success" should be reported as overall technical success during the
same hospitalization period rather than the success of each component of therapy,
although the success of each component of therapy also should be reported.
C 3.2.2 Anatomic and Hemodynamic Improvement
All patients with ALI should have at least a detailed physical examination documenting the con-
dition of the affected leg. This includes the assessment of capillary filling, sensory and motor
function, the presence or absence of pulses, and Doppler arterial studies. Preoperative duplex
imaging or angiography are desirable, but only when the patient's condition permits. The ABPI
is rarely measurable at the time of presentation and in the acute setting tends to improve steadi-
ly after intervention. For these reasons, ABPI change is less useful in the assessment of treat-
ment success in acute as opposed to chronic critical limb ischemia. However, successful revascu-
larization should lead to a measurable ABPI above the "critical range" of 40 to 60 mm Hg. All
patients should therefore have postoperative ABPI recorded and appropriate imaging of the
treated arterial segment to document the anatomic and hemodynamic status. It may be neces-
sary and appropriate to use toe pressures or evaluation of pulse volume recordings to determine
postprocedural hemodynamic status.
Recommendation 52: Hemodynamic status in acute limb ischemia
Patients who have undergone attempted revascularization should have postoperative
ankle or toe pressure measurements and appropriate imaging of the treated arterial seg-
ment in all cases.
C 3.2.3 Effectiveness Assessment
The effectiveness of a procedure is an overall measure of the impact of an intervention on a
patient's life. To accomplish this, physicians need to understand not only the usual clinical crite-
ria of success but also the long-term or serious complications associated with a given therapeutic
modality. Also, understanding how the underlying condition affects a patient's life permits the
estimation of the perceived benefit of a treatment.
Procedural mortality and morbidity
Short-term procedural morbidity refers to those complications of treatment that are of signifi-
cant magnitude to prolong hospitalization or require specific therapy but do not indefinitely
alter the patient's life. The acute morbidity of treatment is related to the severity of ischemia
and the therapeutic modality employed. Overall, procedural complications are common, occur-
ring in more than 50% of patienrs. 6,7,8,9 Acute, limb-threatening ischemia has a significant mor-
tality both because of the underlying diseases that induce or are associated with it and because
of the metabolic derangement that occurs as a result of the acute insult.
[ivegard et al10 identified five admission criteria, each of which will significantly predict a high
risk of cardiac death: mean arterial pressure of less than 90 mm Hg, clinical signs of cardiac fail-
ure, ischemia extending to the thigh, a hemoglobin level over 14 g/dl., and a history of
myocardial infarction in the previous 4 weeks.
The sudden interruption of flow to the leg may be caused by either thrombosis or embolism.
Emboli may be from cardiac or proximal arterial sources. Atrial fibrillation is the most common
source of emboli. Typically, patients with ALI are elderly. Thus, preexisting cardiac or cerebra!
problems are common in patients presenting with acute hypoperfusion of the leg. Myocardial
infarction or fatal arrhythmia account for most of the deaths in this group of patients. Despite
advances in rcvascularization and cardiac support, the mortality ofALI remains high (10% to
20%) and even higher in elderly subjects,l,2,3,4,5,6
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As with the treatment of all forms of disease, long-term procedural complications include not
only those inflicting permanent disabilities but all those that negatively alter or significantly
delay the patient's progress toward improvement. For the assessment of effectiveness of therapy,
complications that yield serious or long-term morbidity must be evaluated and weighed against
the benefit achieved. Although the most obvious source of long-term morbidity may be limb
loss, a more significant complication resulting from the treatment of ALI may be renal failure
from myoglobinuria. Myoglobin is a direct renal toxin, so the resultant renal failure may be
severe and prolonged, requiring the patient to be placed on hemodialysis. As an independent
procedure, hemodialysis is associated with a yearly mortality of nearly 10%11
Limb loss represents treatment failure for patients with severity levels IIa and IIb acute limb
ischemia. This may be attributable to the inability to extract sufficient clot or to treat all of the
offending occlusive disease or to a delay in therapy resulting in diffuse myonecrosis. Limb loss is
associated with a significant and permanent alteration in patient lifestyle and often requires pro-
longed rehabilitation (see also Amputation, D 4.17, P 5267).
Recurrence ofsymptoms
Acute limb ischemia associated with embolization has a significant incidence of recurrence.
Recurrent ischemia caused by embolization may be experienced by as many as 43% of patients in
the absence of anticoagulation.l- Each episode reduces the likelihood of complete restoration of
blood flow into the leg and foot. In addition, the sites of recurrent embolization may vary and
may include arch or visceral vessels leading to patient death.l 3,14 Ischemia from thrombosis is
also associated with a high incidence ofrecurrence.l 5,16 Acute thrombosis generally occurs in
the setting of atherosclerosis, so acute arterial reocclusion is common if no additional interven-
tion for the treatment of the underlying occlusive lesions is undertaken. This is well document-
ed for both thrombolytic therapy and for open thromboembolectomy. In the former, the inci-
dence of recurrent ischemia may be as high as 53%,17,18 whereas the latter may be associated
with an incidence of reocclusion of 21% to 26%.19,20
Health-related quality of life
As defined in A 3.2.8, Valuing Health-Related Quality of Life and Utility Assessment, assess-
ment of health-related quality oflife attempts to identify the general well-being of a patient
through evaluation of overall functional status, perceived health, psychological well-being, and
role function. Currently, this is most easily accomplished by use of the SF-36 assessment tool.
Although patients with ALI of severity levels IIa, IIb, or III may not be able to complete this
questionnaire before intervention, tlle assessment tool may provide insight into the status of the
patient during recovery (see Recommendation 3, p 541).
Recommendation 53: Assessment of quality of life after treatment of acute limb ischemia.
A validated quality-of-life questionnaire is recommended to measure generic health status
after treatment in patients with acute limb ischemia of severity levels ITa, lIb, or early III.
Functional status
The fi.mctional status of the patient posttreatment can be evaluated through the use of a disease-
specific questionnaire and correlated with walking distance if there are no residual foot lesions,
nerve deficits, or muscle fibrosis. Often there is insufficient time to evaluate functional status
before treatment because of the need to proceed to intervention. However posttreatment evalu-
ation is still useful even if baseline values have not been obtained and particularly when compar-
ing two treatments or when a patient was originally asymptomatic. The Walking Impairment
Questionnaire (WIQ) had been designed to evaluate the impact of mild to moderate limb
ischemia on leg function. There are no currently available disease-specific instruments directed
toward the evaluation of patients with acute limb ischemia, and currently the VVIQ may be the
best option (see Recommendation 2, p 539, and Critical Issue 2, p S39).
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Recommendation 54: Parameters for reporting the success of treatment for acute limb
ischemia.
In determining the success of a treatment procedure for acute limb ischemia of severity
levels IIa, lIb, or early III, the following outcomes should be documented: .
1. Objective outcome: Event-free survival, limb salvage, tissue salvage, neurological
status of the limb, renal status, procedural morbidity, preservation of function of
the intact and healed target limb as measured by standardized reporting criteria,
including technical success, hemodynamic status, and claudication distance, how
ever measured.
2. Symptomatic outcome: Limb pain and function.
3. General quality of life: A return over time of the attributes to a pre-acute state or
to the level reported by those patients with similar comorbidities (eg, as measured
by the SF·36 questionnaire).
4. Postrevascularization: Limb retention and function, the need for additional thera-
pies, and proof of patency of the revascularized segment (see A 3.2.9).
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